Psychedelic Stocks New Research Shows That Psychedelic 5-Methocy-N,-N-Dimethyltryptamine Can Improve Anxiety And Depression By Larry Zweig December 02, 2020 A recent John Hopkins study has established that the use of synthetic psychedelic 5-methocy-N,-N-dimethyltryptamine (5-MeO-DMT) is related to unintentional improvement in self-reported anxiety and depression. 5-MeO-DMT is a psyche...
